Evicenter
MarkdownMedical informationP&T meetings
Obefazimod (ABX464)

Ulcerative colitis

Manufacturer
Abivax
Launch
Not announced
Last updated
173 sources

Product information and disease descriptionPlace of product in therapyDisease description

Natural history, survival, and mortality

6 evidence topics · 7 sources

Disease course: relapsing and remitting, with relapse in 70% to 80% by 10 years